Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Hamilton

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Expert Opinion on Investigational Drugs|July 2, 2005
Anticancer activity of farnesyltransferase and geranylgeranyltransferase I inhibitors: prospects for drug developmentS M Sebti, A D Hamilton
Biochemical Society Transactions|August 1, 1996
Rational design of Ras prenyltransferase inhibitors as potential anticancer drugsS M Sebti, A D Hamilton
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis and binding studies of a 1-alkyl-3,6-diamino-4-quinolone based receptor for N-acylated dipeptidesW S Weiner, A D Hamilton
Organic Letters|July 6, 2000
Protein surface recognition by synthetic receptors based on a tetraphenylporphyrin scaffoldR K Jain, A D Hamilton
Oncogene|June 28, 2001
Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studiesS M Sebti, A D Hamilton
The British Journal of Dermatology|January 31, 2012
Medical professional involvement in smartphone 'apps' in dermatologyA D Hamilton, R R W Brady
Biopolymers|January 1, 1997
Farnesyltransferase as a target for anticancer drug designY Qian, S M Sebti, A D Hamilton
Current Opinion in Chemical Biology|July 17, 1998
Recognition of neutral species with synthetic receptorsH Chen, W S Weiner, A D Hamilton
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 12, 2000
Nitronate anion recognition and modulation of ambident reactivity by hydrogen-bonding receptorsB R Linton, M S Goodman, A D Hamilton
Biochemical and Biophysical Research Communications|September 30, 1980
Ferrochelatase: isolation and purification via affinity chromatographyK Mailer, R Poulson, D Dolphin, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Expert Opinion on Investigational Drugs|July 2, 2005
Anticancer activity of farnesyltransferase and geranylgeranyltransferase I inhibitors: prospects for drug developmentS M Sebti, A D Hamilton
Biochemical Society Transactions|August 1, 1996
Rational design of Ras prenyltransferase inhibitors as potential anticancer drugsS M Sebti, A D Hamilton
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis and binding studies of a 1-alkyl-3,6-diamino-4-quinolone based receptor for N-acylated dipeptidesW S Weiner, A D Hamilton
Organic Letters|July 6, 2000
Protein surface recognition by synthetic receptors based on a tetraphenylporphyrin scaffoldR K Jain, A D Hamilton
Oncogene|June 28, 2001
Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studiesS M Sebti, A D Hamilton
The British Journal of Dermatology|January 31, 2012
Medical professional involvement in smartphone 'apps' in dermatologyA D Hamilton, R R W Brady
Biopolymers|January 1, 1997
Farnesyltransferase as a target for anticancer drug designY Qian, S M Sebti, A D Hamilton
Current Opinion in Chemical Biology|July 17, 1998
Recognition of neutral species with synthetic receptorsH Chen, W S Weiner, A D Hamilton
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 12, 2000
Nitronate anion recognition and modulation of ambident reactivity by hydrogen-bonding receptorsB R Linton, M S Goodman, A D Hamilton
Biochemical and Biophysical Research Communications|September 30, 1980
Ferrochelatase: isolation and purification via affinity chromatographyK Mailer, R Poulson, D Dolphin, et al.
Pageof 9